Figure 1
From: Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer
Patients who underwent optimal secondary CRS had longer OS and TTP durations than those who did not undergo (1A, 1B).
Figure 1 | Journal of Experimental & Clinical Cancer Research